Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions
Authors
Keywords
Vasoactive intestinal peptide, Autoimmunity, Inflammation, Neuroinflammation, Neuropeptides/neurotransmitters
Journal
AMINO ACIDS
Volume 45, Issue 1, Pages 25-39
Publisher
Springer Nature
Online
2011-12-03
DOI
10.1007/s00726-011-1184-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutting Edge: Vasoactive Intestinal Peptide (VIP) Induces Differentiation of Th17 Cells with a Distinctive Cytokine Profile
- (2014) M. Yadav et al. JOURNAL OF IMMUNOLOGY
- VIP-induced Neuroprotection of the Developing Brain
- (2011) Sandrine Passemard et al. CURRENT PHARMACEUTICAL DESIGN
- VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling
- (2011) Sandrine Passemard et al. JOURNAL OF CLINICAL INVESTIGATION
- Absence of Vasoactive Intestinal Peptide Expression in Hematopoietic Cells Enhances Th1 Polarization and Antiviral Immunity in Mice
- (2011) J.-M. Li et al. JOURNAL OF IMMUNOLOGY
- VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies
- (2011) Terry W Moody et al. Current Opinion in Endocrinology Diabetes and Obesity
- Inhaled Vasoactive Intestinal Peptide Exerts Immunoregulatory Effects in Sarcoidosis
- (2010) Antje Prasse et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis
- (2010) Shaohua Deng et al. CELLULAR IMMUNOLOGY
- Pituitary adenylate cyclase-activating peptide receptor 1 mediates anti-inflammatory effects in allergic airway inflammation in mice
- (2010) H. D. Lauenstein et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Neuropeptides: keeping the balance between pathogen immunity and immune tolerance
- (2010) Elena Gonzalez-Rey et al. CURRENT OPINION IN PHARMACOLOGY
- Neuropeptide Receptors in Intestinal Disease: Physiology and Therapeutic Potential
- (2010) Susanne Snoek et al. CURRENT PHARMACEUTICAL DESIGN
- Inhalable powder formulation of vasoactive intestinal peptide derivative, [R15,20,21, L17]-VIP-GRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats
- (2010) Satomi Onoue et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes
- (2010) Rebeca Jimeno et al. IMMUNOLOGY AND CELL BIOLOGY
- Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s Disease
- (2010) Ashley D. Reynolds et al. JOURNAL OF IMMUNOLOGY
- Vasoactive Intestinal Peptide Induces Cell Cycle Arrest and Regulatory Functions in Human T Cells at Multiple Levels
- (2010) P. Anderson et al. MOLECULAR AND CELLULAR BIOLOGY
- Dendritic Cells Transduced With Lentiviral Vectors Expressing VIP Differentiate Into VIP-secreting Tolerogenic-like DCs
- (2010) Miguel G Toscano et al. MOLECULAR THERAPY
- The absence of VPAC2 leads to aberrant antibody production in Aspergillus fumigatus sensitized and challenged mice
- (2010) Amali E. Samarasinghe et al. PEPTIDES
- Anti-hyperglycemic, antioxidant and anti-inflammatory effects of VIP and a VPAC1 agonist on streptozotocin-induced diabetic mice
- (2010) Rongjie Yu et al. PEPTIDES
- Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis
- (2010) C. Abad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Therapeutic Effect of Vasoactive Intestinal Peptide on Experimental Arthritis is Associated with CD4+CD25+ T Regulatory Cells
- (2010) G. Chen et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells
- (2009) Laura Fraccaroli et al. BRITISH JOURNAL OF PHARMACOLOGY
- Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease
- (2009) S. G. R. Smalley et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Vasoactive intestinal peptide attenuates concanavalin A-mediated liver injury
- (2009) Qingqiong Luo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages
- (2009) Juan Luis Herrera et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Induction of Alloantigen-Specific Human T Regulatory Cells by Vasoactive Intestinal Peptide
- (2009) D. Pozo et al. JOURNAL OF IMMUNOLOGY
- Vasoactive Intestinal Peptide (VIP) Treatment of Parkinsonian Rats Increases Thalamic Gamma-Aminobutyric Acid (GABA) Levels and Alters the Release of Nerve Growth Factor (NGF) by Mast Cells
- (2009) Orhan Tansel Korkmaz et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Protective Effect of Intravitreal Injection of Vasoactive Intestinal Peptide–Loaded Liposomes on Experimental Autoimmune Uveoretinitis
- (2009) Serge Camelo et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
- (2009) D. Vaudry et al. PHARMACOLOGICAL REVIEWS
- Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis
- (2009) Yossan-Var Tan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuropeptides Rescue Mice from Lethal Sepsis by Down-regulating Secretion of the Late-Acting Inflammatory Mediator High Mobility Group Box 1
- (2008) Alejo Chorny et al. AMERICAN JOURNAL OF PATHOLOGY
- Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts
- (2008) Yasmina Juarranz et al. ARTHRITIS AND RHEUMATISM
- In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis
- (2008) Mario Delgado et al. ARTHRITIS AND RHEUMATISM
- Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells
- (2008) Mario Delgado et al. ARTHRITIS AND RHEUMATISM
- Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death
- (2008) M Delgado et al. CELL DEATH AND DIFFERENTIATION
- Inhalation of vasoactive intestinal peptide in pulmonary hypertension
- (2008) H. H. Leuchte et al. EUROPEAN RESPIRATORY JOURNAL
- A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B *2705 in Sardinia
- (2008) F Paladini et al. GENES AND IMMUNITY
- Vasoactive intestinal peptide protects against β-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels
- (2008) Mario Delgado et al. GLIA
- Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites
- (2008) Ikhlas A. El Karim et al. JOURNAL OF NEUROIMMUNOLOGY
- VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4
- (2008) Alicia Arranz et al. PEPTIDES
- VPAC and PAC receptors: From ligands to function
- (2008) Louise Dickson et al. PHARMACOLOGY & THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now